Genmab A (GMAB) Assets Average (2019 - 2026)

Genmab A (GMAB) has reported Assets Average for 8 consecutive years, with $12.4 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 90.74% year-over-year to $12.4 billion; the trailing twelve-month figure through Jun 2026 stood at $12.4 billion (up 90.74% YoY), and the FY2025 full-year result was $9.7 billion, changed N/A from the prior year.
• Assets Average declined to $12.4 billion in Q2 2026 per GMAB's latest filing, from $12.6 billion in the prior quarter.
• Across five years, Assets Average topped out at $12.6 billion in Q1 2026 and bottomed at $2.7 billion in Q2 2022.
• Historically, Assets Average has averaged $4.7 billion across 5 years, with a median of $3.6 billion in 2023.
• The sharpest annual moves came in 2024 and 2026: Assets Average dropped 5.31% in 2024, then soared 132.74% in 2026.
• Over 5 years, Assets Average stood at $2.9 billion in 2022, then rose by 13.84% to $3.3 billion in 2023, then grew by 22.67% to $4.0 billion in 2024, then jumped by 70.73% to $6.9 billion in 2025, then surged by 80.67% to $12.4 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $12.4 billion, $12.6 billion, and $6.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.